Christopher Viehbacher

Sanofi, Biogen, Reata Pharmaceuticals, Christopher Viehbacher,

Sanofi Fails to Secure Reata in Bidding Battle Against Biogen Following Horizon Setback

Anika Sharma

Biogen’s pursuit of Reata, a rare disease company based in Texas, has unveiled a compelling narrative of corporate rivalry and ...